InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（3 笔）
内部人交易记录
首席执行官已披露买入
2
已披露卖出
3
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the complete record of transactions filed by Doyle William F, Président Exécutif. Officer active across 2 companies, notably NovoCure Ltd. Cumulatively, 10 disclosures have been recorded. Breakdown: 2 buys · 3 sells. Total volume traded: €794k. History available since 2 August 2021. The latest transaction was filed on 3 March 2026 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Doyle William F
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报10 总计
200,000 股0Ordinary SharesSEC:0001194459-26-000001:0
18,169 股0Common StockSEC:0001415889-24-028153:0
15,000 股@ US$16.9851.2% 占其流量Common StockSEC:0001415889-24-014279:0
标准退出：2024年8月19日 (T+90)
15,000 股@ US$16.3048.8% 占其流量Common StockSEC:0001415889-24-007635:0
标准退出：2024年6月6日 (T+90)
20,374 股0Common StockSEC:0001415889-23-015780:0
18,649 股0Common StockSEC:0001415889-22-011980:0
837 股@ US$69.65912.4% 占其流量Ordinary SharesSEC:0001645113-22-000071:0
2,385 股@ US$70.1045.7% 占其流量Ordinary SharesSEC:0001645113-22-000024:0
7,307 股0Common StockSEC:0001179110-21-010527:0
995 股@ US$149.37837.2% 占其流量Ordinary SharesSEC:0001645113-21-000096:0
10 条申报中的 10 条
About Doyle William F
DOYLE WILLIAM F is Président Exécutif. He is also a Director at Elanco Animal Health Inc and Executive Chairman at NovoCure Ltd. His 10 filings cover the most recent filings we hold, from 2021-08-04 to 2026-03-05, with EUR 457919 of purchases and EUR 336451 of sales, and the modal transaction nature is Attribution.
